TRANSWELL BIOTECH CO., LTD.
Area: Government, Academia and Research Institutes
Booth No: N/A
Website: http://www.tw-bio.com
Exhibitor Profile
TRANSWELL BIOTECH focuses on regenerative medicine, wound care, cell therapy, and aesthetic medicine. Our key products: 1. TWB-103 Allogeneic Fibroblast product, completed Phase I/II trials for donor site wounds and Phase I for diabetic foot ulcers, approved by MOHW; 2. auniGEL Hydrogel, Class II wound dressing (TFDA No. 008424); 3. Skincare hydrogel, a registered cosmetic (No. 29167921CHSP2024041101); 4. EpiV Medium, serum-free, chemically-defined epithelial cell culture medium; 5. Exosomes.
Brands
TWB-103 Dermal Fibroblast Cell Therapy Product, Hydrogel Products, EpiV Serum-free Epithelial Cell Culture Medium, Exosome, etc.
Video
Exhibit Products
-
Cell-fm
-
Hydrogel Skincare product
-
auniGEL Hydrogel
-
Exosomes/Extracellular Vesicles
-
EpiV Serum-free, Chemically-defined Epithelial Cell Culture Medium
-
TWB-103 Allogeneic Dermal Fibroblast Cell Therapy Product
Exhibitors you may be interested in
Highest Rated
